The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
(R)-2-((R)-3-Amino-3-(4-((2-(2-isopropoxyethyl)quinolin-4-yl)methoxy)phenyl)-2-oxopyrrolidin-1-yl)-N-hydroxy-4-methylpentanamide ID: ALA3221866
PubChem CID: 90668121
Max Phase: Preclinical
Molecular Formula: C31H40N4O5
Molecular Weight: 548.68
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: CC(C)C[C@H](C(=O)NO)N1CC[C@@](N)(c2ccc(OCc3cc(CCOC(C)C)nc4ccccc34)cc2)C1=O
Standard InChI: InChI=1S/C31H40N4O5/c1-20(2)17-28(29(36)34-38)35-15-14-31(32,30(35)37)23-9-11-25(12-10-23)40-19-22-18-24(13-16-39-21(3)4)33-27-8-6-5-7-26(22)27/h5-12,18,20-21,28,38H,13-17,19,32H2,1-4H3,(H,34,36)/t28-,31-/m1/s1
Standard InChI Key: HJQQUQIRQGCITO-GRKNLSHJSA-N
Molfile:
RDKit 2D
40 43 0 0 0 0 0 0 0 0999 V2000
12.8303 -5.6111 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
13.2408 -4.8940 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.0474 -5.0683 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.1351 -5.8887 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.3825 -6.2209 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.9043 -4.1415 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
14.8724 -5.0683 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.2871 -4.3512 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.1121 -4.3512 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.5226 -5.0683 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.1121 -5.7810 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.2871 -5.7810 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.3518 -5.0683 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
17.7621 -5.7810 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.2372 -5.7810 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
19.8268 -6.4938 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.0018 -6.4938 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.5871 -5.7810 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.0018 -5.0683 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.5871 -4.3512 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.0018 -3.6385 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.8268 -3.6385 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.2372 -4.3512 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.8268 -5.0683 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.7140 -6.4681 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.0100 -5.6944 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.4871 -5.0561 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.6723 -5.1829 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.3764 -5.9522 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.1536 -4.5404 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.8868 -6.6000 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
12.2419 -7.1185 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
11.9426 -7.9009 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
20.2460 -7.2191 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.8277 -7.9447 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.2469 -8.6700 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
19.8285 -9.3957 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.2478 -10.1209 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.9908 -9.3962 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.1351 -4.2480 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 1 0
3 4 1 0
4 5 1 0
1 5 1 0
2 6 2 0
7 8 1 0
8 9 2 0
9 10 1 0
10 11 2 0
11 12 1 0
7 12 2 0
13 14 1 0
15 16 2 0
16 17 1 0
17 18 2 0
18 19 1 0
19 20 2 0
20 21 1 0
21 22 2 0
22 23 1 0
23 24 2 0
15 24 1 0
19 24 1 0
14 18 1 0
10 13 1 0
3 7 1 0
25 26 1 0
26 27 1 1
27 28 1 0
28 29 1 0
28 30 1 0
1 26 1 0
25 31 2 0
25 32 1 0
32 33 1 0
16 34 1 0
34 35 1 0
35 36 1 0
36 37 1 0
37 38 1 0
37 39 1 0
3 40 1 1
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 548.68Molecular Weight (Monoisotopic): 548.2999AlogP: 4.09#Rotatable Bonds: 12Polar Surface Area: 127.01Molecular Species: NEUTRALHBA: 7HBD: 3#RO5 Violations: 1HBA (Lipinski): 9HBD (Lipinski): 4#RO5 Violations (Lipinski): 1CX Acidic pKa: 8.74CX Basic pKa: 7.46CX LogP: 3.39CX LogD: 3.22Aromatic Rings: 3Heavy Atoms: 40QED Weighted: 0.23Np Likeness Score: -0.44
References 1. Argade A, Bahekar R, Desai J, Thombare P, Shah K, Gite S, Sunder R, Ranvir R, Bandyopadhyay D, Chakrabarti G, Joharapurkar A, Mahapatra J, Chatterjee A, Patel H, Shaikh M, Sairam KVVM, Jain M, Patel P. (2011) Design, synthesis and biological evaluation of -lactam hydroxamate based TACE inhibitors, 2 (10): [10.1039/C0MD00261E ]